Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Heritage Bio Labs

Research Library

Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.

Browse by productGeneral topics

Find articles

Matching articles

Showing 37–48 of 77 articles · Interpret the evidence

Clear search and filters

  • Interpret the evidence

    How a rat tracer study separated blood clearance from tissue distribution

    Peptides are short amino-acid chains held together by peptide bonds. Signaling chains can move between blood and tissue, and researchers can label them to follow where they go. IGF-1 DES 1,3 commonly denotes des(1–3)IGF-1, a form of insulin-like growth factor 1 missing its first three amino acids.

    IGF-1 DES 1,31 source (1991)

  • Interpret the evidence

    What a 2026 cell-culture study can tell us about one ingredient in a complex medium

    IGF-LR3, or Long R3 IGF-1, is an engineered 83-residue analogue of human insulin-like growth factor 1. It has an extension at the beginning and an arginine substitution at position three of the original IGF-1 sequence.

    IGF-LR32 sources (1992, 2026)

  • Interpret the evidence

    Why an amyloid plaque change did not establish cognitive improvement

    IGF-LR3 is an engineered form of insulin-like growth factor 1 with a 13-residue extension and an arginine substitution. In a mouse study, researchers asked whether exposing the brain to this variant changed amyloid deposits and performance on behavioral tests.

    IGF-LR32 sources (1992, 2024)

  • Interpret the evidence

    Why Long R3 did not appear equally potent in every cell system

    IGF-LR3 is an engineered version of human insulin-like growth factor 1. It adds 13 residues to the beginning and replaces glutamate with arginine at the third position of the original sequence. Researchers used this design to ask how binding proteins change a growth factor's apparent potency.

    IGF-LR31 source (1992)

  • Interpret the evidence

    Why weight and vomiting were separate outcomes in a ferret experiment

    Ipamorelin is a synthetic five-residue peptide that activates the ghrelin receptor, also called the growth hormone secretagogue receptor. A study in ferrets asked whether this signal affected weight change and vomiting after exposure to a chemotherapy drug.

    Ipamorelin2 sources (2024)

  • Interpret the evidence

    Why the stomach and isolated muscle were studied separately in rats

    Ipamorelin is a synthetic five-amino-acid peptide that activates the ghrelin receptor. An animal study asked whether it changed how quickly the stomach emptied after surgery and whether it also affected contractions in stomach tissue studied outside the body.

    Ipamorelin2 sources (2012, 2014)

  • Interpret the evidence

    What KPV Skin Cell Research Does and Does Not Show About KLOW

    KPV is a short chain named in the KLOW blend alongside BPC-157, TB-500 and the copper complex GHK-Cu. One reason for studying KPV is to understand how it interacts with inflammatory signals. The older direct skin cell study described here is evidence about KPV alone.

    KLOW Blend2 sources (2025, 2026)

  • Interpret the evidence

    Why KPV Lipid Findings Do Not Predict KLOW Effects in the Liver

    KPV is a three-amino-acid peptide named as one ingredient of KLOW. A 2026 experiment measured how KPV changed the accumulation of fat in a laboratory model using human-derived liver cells. The study investigated KPV under defined conditions and did not evaluate the four-component blend.

    KLOW Blend1 source (2026)

  • Interpret the evidence

    Why Tendon Strength and Inflammation Are Separate Outcomes in KLOW Research

    KLOW is a blend label that refers here to BPC-157, TB-500, KPV and GHK-Cu. Research about its individual ingredients sometimes uses broad language about recovery.

    KLOW Blend2 sources (2026)

  • Interpret the evidence

    What two mouse colitis models added to the evidence

    KPV is a three-amino-acid fragment of alpha-melanocyte-stimulating hormone. An older 2008 paper compared outcomes in two models of intestinal inflammation in mice. The authors asked whether a tissue response could be seen in more than one kind of animal model.

    KPV1 source (2008)

  • Interpret the evidence

    Why a trial of a different tripeptide cannot answer for KPV

    KPV is a three-amino-acid fragment of alpha-melanocyte-stimulating hormone. An older randomized study in people with ulcerative colitis investigated a separate three-amino-acid molecule called K(D)PT. The similar names can obscure which peptide was actually tested.

    KPV3 sources (2007–2026)

  • Interpret the evidence

    What pediatric clinic records add to the liraglutide evidence

    Liraglutide is a modified peptide that activates the glucagon-like peptide-1, or GLP-1, receptor. In 2026, investigators examined health records to see how blood sugar measures changed in young people with type 2 diabetes who received liraglutide in a clinical setting.

    Liraglutide3 sources (2025, 2026)

Browse by product

General topics

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Library index (JSON)